Previous studies have demonstrated the relationship between obesity, hyperleptinemia and reduced insulin sensitivity and the beneficial effect of weight loss on insulin action [36], [37]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.